USADA funds the development of HGH urine test
Human growth hormone (HGH) is a performance-enhancing drug. It has the ability to grow muscle and aid recovery after training. It is not detectable in urine, unlike anabolic steroids. That’s why the American Doping Agency (USADA) has agreed to fund the development of HGH (human growth hormone) urine test. They have agreed to pay $65,000 to Ceres Nanosciences LLLP, who will develop the test which will help USADA enormously in doping detection.
“From a scientific perspective, we can tell you now if someone’s been doping,” said Tom Dunlap, one of the developers from Ceres. He also said that the development will last about a year — it will take around six months to make Ceres’ patented technology detect human growth hormone, and another six months to perform all necessary tests in order to make the technique flawless.
“This is a great example of the partnerships that must be forged between cutting-edge biotech companies and the anti- doping movement to ensure that the rights of clean athletes are protected,” said Larry Bowers from USADA.
Adopted from materials found at Bloomberg.com
